Sector
Healthcare
One of the most prominent practices in Europe, on a growing resilient sector, underpinned by constant innovation in biotech and medtech, and long-term demand for healthcare services.
Bryan, Garnier & Co's insights and news
Read the latest news, reports and newsletters from Europe’s Growth Investment Bank to find out more about current trends impacting investment banking activity and company performance.
28 April 2023
Welcome to our Q1 2023 Quarterly Report
Welcome to our Q1 2023 Quarterly Report. For this edition, we have…
27 April 2023
Activity Report 2022
The year 2022 presented significant economic challenges, including…
14 April 2023
Navigating the ever-evolving advertising landscape: Performance-based advertising needs are driving a sizzling M&A market
PARIS | LONDON | April 14th, 2023 – BG IRIS, Bryan Garnier’s…
15 March 2023
Falk Mueller-Veerse, Partner & Head of DACH at Bryan, Garnier & Co, presided the selection panel of the Tech Tour Growth50 for the 2023 edition
15 March 2023 | IN BG&CO BUSINESS NEWS Bryan, Garnier & Co,…
14 March 2023
Sourcing it up: Growth opportunities in the TIC sector
PARIS | LONDON | March 14th, 2023 –BG IRIS, Bryan Garnier’s research…
24 February 2023
Lhyfe IPO wins Sustainable Equity Issue of the Year at IFR Awards 2022
The IPO of green hydrogen company Lhyfe has won Sustainable Equity…
22 February 2023
Software and SaaS valuations: When quality matters more than ever
PARIS | LONDON | February 15th, 2023 Bryan, Garnier & Co’s…
Healthcare transactions
Bryan, Garnier & Co offers a complete range of investment banking services, from growth financing to mergers and acquisitions.